Her-2 neu negative lipid rich breast carcinoma in an immunocompromised patient

• Main Authors: Deepika Sirohi, M.D (Author), Kent Swimley (Author), Amanda L. Profit, M.D (Author), Nicole D. Riddle, M.D (Author)
• Formato: Livro
• Publicado em: Elsevier, 2015-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Lipid-rich breast carcinoma (LRBC) is rare cancer considered to be a variant of invasive ductal breast carcinoma. It is characterized by an aggressive behavior and poor prognosis and requires prompt recognition and close follow-up. The tumor derives its name from the intracytoplasmic neutral lipid t...